Cyclacel Pharmaceuticals's total assets for Q1 2025 were $3.73M, a decrease of -8.79% from the previous quarter. CYCC total liabilities were $672.00K for the fiscal quarter, a -89.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.